# ASA in Prevention of Ovarian Cancer (STICs and STONEs)

> **NCT03480776** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Canadian Cancer Trials Group** · enrollment: 117 (actual)

## Conditions studied

- Ovarian Cancer Prevention

## Interventions

- **DRUG:** Acetylsalicylic acid
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT03480776
- **Lead sponsor:** Canadian Cancer Trials Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2018-07-24
- **Primary completion:** 2026-06-30
- **Final completion:** 2026-09-15
- **Target enrollment:** 117 (ACTUAL)
- **Last updated:** 2026-01-14

## Collaborators

- Apotex Inc.

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03480776

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03480776, "ASA in Prevention of Ovarian Cancer (STICs and STONEs)". Retrieved via AI Analytics 2026-05-19 from https://api.ai-analytics.org/clinical/NCT03480776. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*